IBRX

NASDAQ · Biotechnology

Immunitybio Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.32

+0.10 (+1.39%)

Day Range $7.00 — $7.60

52W Range $1.95 — $12.43

Performance

1D —

1W —

1M —

3M —

6M +242.06%

1Y +162.37%

YTD +262.38%

Open$7.05

Previous Close$7.22

Day High$7.60

Day Low$7.00

52W High$12.43

52W Low$1.95

Volume—

Avg Volume11.32M

Market Cap7.71B

P/E Ratio—

EPS$-0.85

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $4.22 Above

SMA 200 $2.95 Above

RSI (14) 70.9 Overbought

Trend Golden Cross Bullish

Analyst Ratings

Strong Buy

10 analysts

9 Buy 1 Hold 0 Sell

Price Target +1,386.2% upside

Current
$7.32

Target
$108.79

$71.54 $108.79 avg $142.95

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	129.03M	1.55B	1.61B
Net Income	-400,089,225	174.18M	206.87M
Profit Margin	-310.2%	11.2%	12.9%
EBITDA	-273,883,069	310.76M	319.11M
Free Cash Flow	—	125.72M	219.44M
Rev Growth	+678.6%	+14.4%	+15.1%
Debt/Equity	0.01	0.68	0.80

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$234.76	+2.07%	105.2	382.49B
AMGN	Amgen Inc	$347.01	+0.66%	23.4	182.21B
GILD	Gilead Sciences Inc	$125.05	+0.14%	16.7	153.66B
VRTX	Vertex Pharmaceuticals Inc	$468.42	+0.35%	26.4	114.63B
REGN	Regeneron Pharmaceuticals	$618.03	+0.90%	14.5	63.95B
ALNY	Alnylam Pharmaceuticals Inc	$288.18	+0.62%	64.3	37.13B